Document is current
Any future updates will be listed below
-
Authors
Greene, Michelle K.
Chen, Ting
Robinson, Eifion
Straubinger, Ninfa L.
Minx, Charlene
Chan, Darren K. W.
Wang, Jun
Burrows, James F.
Van Schaeybroeck, Sandra
Baker, James R.
Caddick, Stephen
Longley, Daniel B.
Mager, Donald E.
Straubinger, Robert M.
Chudasama, Vijay
Scott, Christopher J. https://orcid.org/0000-0002-7582-3808
- License Information
-
More Information
Article History
Received: 9 December 2019
Revised: 27 July 2020
Accepted: 13 August 2020
First Online: 11 September 2020
Ethics approval and consent to participate
: All animal experimentation was approved in advance by the Institutional Animal Care and Use Committee (IACUC) of Roswell Park Comprehensive Cancer Center (Buffalo, NY). MIA PaCa-2 and PANC-1 human PaCa cell lines were obtained from the American Type Culture Collection (ATCC), USA.
: Not applicable.
: All data and material requests should be directed to C.J.S. (c.scott@qub.ac.uk), V.C. (v.chudasama@ucl.ac.uk) or R.M.S. (rms@buffalo.edu).
: V.C., J.R.B. and S.C. are Directors of the spin-out ThioLogics and C.J.S. is a consultant for Fusion Antibodies Plc. but there are no direct competing interests to declare.
: These studies were partly funded through a US-Ireland R&D Partnership grant awarded by HSCNI to C.J.S. and D.B.L. (STL/5010/14, MRC grant MC_PC_15013) and grant R01CA198096 awarded by the National Inst. of Health/National Cancer Inst. (USA) to R.M.S. and C.J.S.
